News Details

( As on 21/04/2026 08:20)

OneSource Specialty - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Press release: Orbicular's Partner secures tentative U.S. ANDA approval for a generic version of Ozempic (Semaglutide Injection), supported by OneSource as CDMO Partner.